This volume will cover a series of reviews on stem cells including adult and embryonic stem cells. Speakers were invited to present these talks during the Stem Cell... Læs mere
Chronic diseases are the leading cause of deaths worldwide and according to the World Economics Council and the Harvard School of Public Health, the cost of chronic diseases is expected to reach a staggering 48% of global gross domestic product by the year 2030.
From its chapters on the history and core principles of clinical forensic medicine, right up to the text’s discussion of substance misuse and deaths in... Læs mere
This book collects the latest research mesenchymal stem cells (MSCs), which appear to hold great promise in the quest to develop regenerative cell-based therapy. Conveys a clear understanding of current progress in translation of MSCs from bench to bedside.
For physicians, surgeons, and scientists working on cardiovascular disorders, Applications of Biotechnology in Cardiovascular Therapeutics serves as an invaluable reference by collecting the essential writings of Dr. Kewal K.
All three peroxisome proliferator-activated receptor (PPAR) subtypes share a high degree of structural homology while exhibiting differences in function, tissue distribution, and ligand specificity.
Some of these cell types and various blood-derived cell lineages are involved in the repair of various types of tissue damage that span the spectrum of medical disorders.
The aim of Molecular Mechanisms of Neurotransmitter Release is to provide up-to-date, in-depth coverage of essentially all major mole- lar mechanisms of neurotransmitter release.
Thorough, current and thoughtfully organized, this ideal guide is supplemented by 75 tables and 16 figures as well as numerous references from recent literature, which are appended to each chapter. Includes nanobiology, biotech-based services and more.
Therapeutic applications within regenerative biomedicine has gained tremendous interest from a growing, multidisciplinary community of investigators in recent years, driven by the hope of finding cures for several diseases.
A majority of the Fortune 500 companies implement some practice of workplace drug testing in their company policies. This book covers all major issues concerning how people try to beat drug tests and defend positive test results.
This handbook describes many different types of biomarkers and their discovery. It also presents the background information needed for the evaluation of biomarkers as well as the essential procedures for their validation and use in clinical trials.